The Novo Nordisk Pharmaceutical Company is associating with the HEMS & Hers direct consumption telesalud company to offer Wegovy discount access to Wegovy, a LPG-1 manufactured by Novo Nordisk, the companies announced in Tesday.
HIMS & HERS provides treatments for weight, anxiety, sexual health and other conditions. Through the association, consumers can now access Novocare Pharmacy, the direct delivery option of Novo Nordisk, directly through the Hims & Her platform. From $ 599 per month, consumers can be prescribed Wagovy and receive a HEMS & Hers membership. The liter includes 24/7 attention, clinical support and nutrition guidance.
Before the association, the cost of Wogovy on the Hims & Hers platform was $ 1,999 per month. The price of $ 599 is also set lower than the other LPG-1 sacrificed in Hims & Hers: Ozempic provides for $ 1,799 per months, Mounjaro for $ 1,899 per month and Zepbound for $ 1,899 per month.
This is a long -term association between Hims & Hers and Novo Nordisk, and companies will also create a “road map that combines innovative Novo Nordisk treatments with the ability of Hims and Hers to climb access not to quality care, the announcement.
“Together, we are going to bring more attention options to more Americans and take a first step to demonstrate how access to attention should be and can be seen in the United States,” said Andrew Dudum, CEO and founder of Hims & Hers, in a published video X.
The fact that the two are associated is remarkable, since it occurs shortly after a dispute between companies about the announcement of the Hims and Hers Super Bowl that had the GLP-1 composed of the Telesalud company. These are tailored to aggravating pharmacies and include the same active ingredient found in brand LPG-1 such as Wegovy (Semaglutida) and are much cheaper than brand versions. And it was just that he and she offered LPG-1 compounds. They were also ro, Weightwatchers and other telesalud companies.
In response to the commercial of Hims & Hers, Novo Nordisk presented a printed advertisement in The New York Times and uses Today, stating: “Do you really know what you are injected into your body?” The company argued that compounds are not approved by the FDA and it has not been shown to be safe.
Composite medications can be prescribed when there is a shortage of a medication approved by the FDA, or if the medication approved by the FDA is not appropriate for a patient, as in the case of an allergy. Although there has been a scarcity of semagglutida at the time of the Super Bowl announcement, the FDA has since the shortage has been resolved, decreasing the speed of the prescription of LPG-1 compounds.
Despite the association with Hims & Hers, a spokesman for Novo Nordisk declared that the company’s position in compound Semaglutide remains unchanged. The company also recently won a victory in court against the compounds, defending the determination of the FDA that the scandable scarcity has been resolved.
“We will continuously challenge the illegal use of illicit [active pharmaceutical ingredient] For any organization that participates in such activity, “said Jamie Bennett, the spokesman, in an email.” Doing Wegovy Available through Telesalud channels, with their clinical test loss in its premium feather delivery, it is an important step forward to allow patients to receive care in the way in which they are the medical objectives with the objectives of the objectives of the objectives of the objectives of the objectives of the objective objectives. “
It is also worth noting that Novo Nordisk is not associated only with HIMS and she to sacrifice the GLP-1 with a discount. He is also working with other companies of Telesalud Ro and LifeMD.
Photo of: Michael Siluk/UCG/Universal Images Group through Getty Images